Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
112,774
Employees112,774
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
112,774
Employees112,774

RHHBY Key Statistics

Market cap
322.90B
Market cap322.90B
Price-Earnings ratio
21.08
Price-Earnings ratio21.08
Dividend yield
1.95%
Dividend yield1.95%
Average volume
1.85M
Average volume1.85M
High today
$50.25
High today$50.25
Low today
$49.76
Low today$49.76
Open price
$50.17
Open price$50.17
Volume
458.98K
Volume458.98K
52 Week high
$60.85
52 Week high$60.85
52 Week low
$35.07
52 Week low$35.07

RHHBY News

TipRanks 1d
Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro

Roche (RHHBY) announced that the US Food and Drug Administration has accepted the company’s supplemental Biologics License Application, sBLA, for Gazyva/Gazyvar...

TipRanks 6d
Roche decision could hurt Sarepta in U.S., says H.C. Wainwright

H.C. Wainwright analyst Mitchell Kapoor reiterates a Sell rating on Sarepta (SRPT) with a $5 price target saying Roche’s (RHHBY) new placebo-controlled Phase 3...

Analyst ratings

50%

of 24 ratings
Buy
50%
Hold
37.5%
Sell
12.5%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.